Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA

Next Previous
X
Search
Trial Profile

Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Conbercept (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use

    • Most Recent Events

    • 28 Aug 2020 Planned number of patients changed from 100 to 120, according to trial deisgn published in the Medicine
    • 28 Aug 2020 Trial design published in the Medicine
    • 28 Aug 2020 According to trial design published in the Medicine, Progress of the trial (Till date: 6 July 2020), recruitment has started at all participating sites(n=7) and a total of 28 eyes have been recruited into the trial till date.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top